Hybrid approaches, such as quantum machine learning, are being explored now for their ability to analyze biological data, identify potential drug targets and rapidly predict drug interactions.
Quantum may still be nascent, but it’s already showing incredible potential to transform biotech in areas such as drug discovery. Hybrid approaches, such as quantum machine learning, are being explored now for their ability to analyze biological data, identify potential drug targets and rapidly predict drug interactions. This could unlock new drug treatments for complex diseases such as cancer. - Jeff Wong, EY